富蘭克林坦伯頓全球投資系列-生技領航基金美元I(acc)股
54.24美元0.32(0.59%)
2023/12/08更新
績效 / 1月6.56%
3月1.7%
1年5.19%
晨星評等-
- 1.現金3.87%
- 2.股票10.86%
- 3.債券0.00%
- 4.其他85.27%
- 1.美國84.31%
- 2.英國4.22%
- 3.新興亞洲3.86%
- 4.歐元區2.05%
- 5.歐洲不包含歐元區0.49%
- 1.Amgen Inc8.29%
- 2.Regeneron Pharmaceuticals Inc7.38%
- 3.Vertex Pharmaceuticals Inc6.04%
- 4.Biogen Inc4.85%
- 5.Gilead Sciences Inc4.39%
- 6.Ascendis Pharma A/S ADR4.20%
- 7.AstraZeneca PLC ADR3.93%
- 8.Intra-Cellular Therapies Inc3.67%
- 9.Jazz Pharmaceuticals PLC3.53%
- 10.Seagen Inc Ordinary Shares3.01%
- 1.現金3.87%
- 2.股票10.86%
- 3.債券0.00%
- 4.其他85.27%
- 1.美國84.31%
- 2.英國4.22%
- 3.新興亞洲3.86%
- 4.歐元區2.05%
- 5.歐洲不包含歐元區0.49%
- 1.Amgen Inc8.29%
- 2.Regeneron Pharmaceuticals Inc7.38%
- 3.Vertex Pharmaceuticals Inc6.04%
- 4.Biogen Inc4.85%
- 5.Gilead Sciences Inc4.39%
- 6.Ascendis Pharma A/S ADR4.20%
- 7.AstraZeneca PLC ADR3.93%
- 8.Intra-Cellular Therapies Inc3.67%
- 9.Jazz Pharmaceuticals PLC3.53%
- 10.Seagen Inc Ordinary Shares3.01%